TRICARE Beneficiaries Ages 12 and Older Now Eligible for COVID-19 Vaccine

adolescent TRICARE beneficiaries

With emergency use authorization and a 100-percent efficacy rate for this age group, adolescent TRICARE beneficiaries are strongly recommended to get the COVID-19 vaccine and is an important step in ending the pandemic.

If you’re a parent with a child who’s now eligible for the vaccine, you may have questions about safety. The FDA has conducted a thorough review of the Pfizer vaccine and determined that its potential benefits outweigh potential risks in those 12 years of age and older. According to the FDA evaluation, clinical trials involving 12-15 year olds showed 100% effectiveness, strong antibody responses, and no serious side effects.

learn more